Literature DB >> 741243

High amputation of the sacrum for extirpation of tumors. Principles and technique.

B Stener, B Gunterberg.   

Abstract

A detailed description is given of the principles and surgical technique for extensive resection of the sacrum, including an adjacent part of each ilium, for radical removal of tumor. Two levels of sacral amputation are discussed: between S1 and S2 (through the canals of the S1 nerves) and through S1 (above the canals of the S1 nerves), with or without inclusion of the rectum in the specimen. The former level permits the preservation of the S1 nerves; the latter does not. Important pathoanatomic facts are discussed. The effects of these operations on the urogenital and anorectal function and on the stability of the pelvic girdle are briefly reviewed. Five illustrative cases are reported with comments on the results.

Entities:  

Mesh:

Year:  1978        PMID: 741243     DOI: 10.1097/00007632-197812000-00009

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  34 in total

1.  Mesh reconstruction preventing sacral herniation.

Authors:  K Junge; C J Krones; R Rosch; V Fackeldey; V Schumpelick
Journal:  Hernia       Date:  2003-07-18       Impact factor: 4.739

Review 2.  Management of metastatic sacral tumours.

Authors:  Nasir A Quraishi; Kyriakos E Giannoulis; Kimberley L Edwards; Bronek M Boszczyk
Journal:  Eur Spine J       Date:  2012-06-23       Impact factor: 3.134

3.  Emisacrectomy, experience in 11 cases.

Authors:  Antonio Solini; Giosuè Gargiulo; Gianruggero Fronda; Paolo De Paolis; Nicola Ruggieri; Mauro Garino
Journal:  Eur Spine J       Date:  2009-05-26       Impact factor: 3.134

Review 4.  Residual neurological function after sacral root resection during en-bloc sacrectomy: a systematic review.

Authors:  Carmine Zoccali; Jesse Skoch; Apar S Patel; Christina M Walter; Philip Maykowski; Ali A Baaj
Journal:  Eur Spine J       Date:  2016-02-25       Impact factor: 3.134

5.  Clinical significance of a wide excision policy for sacrococcygeal chordoma.

Authors:  Shunzo Osaka; Osamu Kodoh; Hideyuki Sugita; Eiji Osaka; Yoshiyuki Yoshida; Junnosuke Ryu
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-16       Impact factor: 4.553

6.  Case report 503: Giant cell tumor of sacrum; fibrous histiocytoma of ischium (benign); fibrous histiocytoma of tibia (benign).

Authors:  P Wuisman; A Roessner; A Härle; R Erlemann; M Reiser; M Schmidt
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

7.  Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.

Authors:  Chetan Bettegowda; Stephen Yip; Sheng-Fu Larry Lo; Charles G Fisher; Stefano Boriani; Laurence D Rhines; Joanna Y Wang; Aron Lazary; Marco Gambarotti; Wei-Lien Wang; Alessandro Luzzati; Mark B Dekutoski; Mark H Bilsky; Dean Chou; Michael G Fehlings; Edward F McCarthy; Nasir A Quraishi; Jeremy J Reynolds; Daniel M Sciubba; Richard P Williams; Jean-Paul Wolinsky; Patricia L Zadnik; Ming Zhang; Niccole M Germscheid; Vasiliki Kalampoki; Peter Pal Varga; Ziya L Gokaslan
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

8.  Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.

Authors:  Tong Meng; Huabin Yin; Bo Li; Zhenxi Li; Wei Xu; Wang Zhou; Mo Cheng; Jing Wang; Lei Zhou; Xinghai Yang; Tielong Liu; Wangjun Yan; Dianwen Song; Jianru Xiao
Journal:  Neuro Oncol       Date:  2014-12-08       Impact factor: 12.300

9.  What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?

Authors:  Tao Ji; Wei Guo; Rongli Yang; Xiaodong Tang; Yifei Wang; Lin Huang
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

10.  The problem of stabilization after sacrectomy.

Authors:  G Blatter; E G Halter Ward; G Ruflin; B Jeanneret
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.